Top Biotechnology Startups in 2026

we build proprietary datasets and models in-house to uncover biological insights that support research, biomarker development, and therapeutic discovery. we launch data-driven scientific investigations both for our clients and for our internal research programs. our current work focuses on hormone-related systems. We aim to create predictive discovery models capable of recognizing relationships, predicting patterns, and coming up with actionable scientific insights. currently, we are a small team of individuals passionate about tackling and solving difficult biomedical problems from a data-driven point-of-view. our expertise covers the junction between biological sciences and data science. we are actively looking for qualified data scientists and database developers interested in applying their knowledge to the healthcare industry. we welcome you to join us in NYC!! :)

Amia.ai develops AI systems purpose-built for the life sciences to accelerate regulatory science and reduce operational burden. Its flagship product, MedNova, is an AI copilot for regulatory submission workflows that automates complex documentation like eCTD Modules 3 and 5, enabling teams to prepare FDA- and EMA-ready submissions up to 10x faster. Powered by BioPharmLLM, Amia’s proprietary language model trained on scientific and regulatory data, MedNova delivers safe, auditable outputs designed for GxP environments. Founded by industry veterans from Pfizer, Amgen, and Gilead, Amia.ai serves biotech startups, regulatory consultancies, and enterprise pharma teams seeking next-generation AI tooling built for compliance and accuracy.